<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">35182760</PMID><DateCompleted><Year>2022</Year><Month>06</Month><Day>22</Day></DateCompleted><DateRevised><Year>2024</Year><Month>09</Month><Day>07</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1469-0691</ISSN><JournalIssue CitedMedium="Internet"><Volume>28</Volume><Issue>7</Issue><PubDate><Year>2022</Year><Month>Jul</Month></PubDate></JournalIssue><Title>Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases</Title><ISOAbbreviation>Clin Microbiol Infect</ISOAbbreviation></Journal><ArticleTitle>ESCMID rapid guidelines for assessment and management of long COVID.</ArticleTitle><Pagination><StartPage>955</StartPage><EndPage>972</EndPage><MedlinePgn>955-972</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.cmi.2022.02.018</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1198-743X(22)00092-1</ELocationID><Abstract><AbstractText Label="SCOPE" NlmCategory="METHODS">The aim of these guidelines is to provide evidence-based recommendations for the assessment and management of individuals with persistent symptoms after acute COVID-19 infection and to provide a definition for this entity, termed 'long COVID'.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We performed a search of the literature on studies addressing epidemiology, symptoms, assessment, and treatment of long COVID. The recommendations were grouped by these headings and by organ systems for assessment and treatment. An expert opinion definition of long COVID is provided. Symptoms were reviewed by a search of the available literature. For assessment recommendations, we aimed to perform a diagnostic meta-analysis, but no studies provided relevant results. For treatment recommendations we performed a systematic review of the literature in accordance with the PRISMA statement. We aimed to evaluate patient-related outcomes, including quality of life, return to baseline physical activity, and return to work. Quality assessment of studies included in the systematic review is provided according to study design.</AbstractText><AbstractText Label="RECOMMENDATIONS" NlmCategory="CONCLUSIONS">Evidence was insufficient to provide any recommendation other than conditional guidance. The panel recommends considering routine blood tests, chest imaging, and pulmonary functions tests for patients with persistent respiratory symptoms at 3&#xa0;months. Other tests should be performed mainly to exclude other conditions according to symptoms. For management, no evidence-based recommendations could be provided. Physical and respiratory rehabilitation should be considered. On the basis of limited evidence, the panel suggests designing high-quality prospective clinical studies/trials, including a control group, to further evaluate the assessment and management of individuals with persistent symptoms of COVID-19.</AbstractText><CopyrightInformation>Copyright &#xa9; 2022 European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Yelin</LastName><ForeName>Dana</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>COVID Recovery Clinic, Rabin Medical Center, Beilinson Hospital, Petah-Tikva, Israel; Faculty of Medicine, Tel Aviv University, Ramat Aviv, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Moschopoulos</LastName><ForeName>Charalampos D</ForeName><Initials>CD</Initials><AffiliationInfo><Affiliation>Fourth Department of Internal Medicine, Medical School of Athens, National and Kapodistrian University of Athens, Attikon University Hospital, Athens, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Margalit</LastName><ForeName>Ili</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>COVID Recovery Clinic, Rabin Medical Center, Beilinson Hospital, Petah-Tikva, Israel; Faculty of Medicine, Tel Aviv University, Ramat Aviv, Israel; Infectious Diseases Unit, Rabin Medical Center, Beilinson Hospital, Petah-Tikva, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gkrania-Klotsas</LastName><ForeName>Effrossyni</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Infectious Diseases, Cambridge University Hospitals, NHS Foundation Trust, Cambridge, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Landi</LastName><ForeName>Francesco</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Geriatric Internal Medicine Department, Fondazione Policlinico Universitario A. Gemelli IRCSS, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stahl</LastName><ForeName>Jean-Paul</ForeName><Initials>JP</Initials><AffiliationInfo><Affiliation>Infectious Diseases Department, University and Hospital Grenoble Alpes, Grenoble Cedex, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yahav</LastName><ForeName>Dafna</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Fourth Department of Internal Medicine, Medical School of Athens, National and Kapodistrian University of Athens, Attikon University Hospital, Athens, Greece; Infectious Diseases Unit, Rabin Medical Center, Beilinson Hospital, Petah-Tikva, Israel. Electronic address: dafna.yahav@gmail.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D017065">Practice Guideline</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>02</Month><Day>17</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Clin Microbiol Infect</MedlineTA><NlmUniqueID>9516420</NlmUniqueID><ISSNLinking>1198-743X</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019317" MajorTopicYN="N">Evidence-Based Medicine</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011788" MajorTopicYN="N">Quality of Life</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020127" MajorTopicYN="N">Recovery of Function</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D062707" MajorTopicYN="N">Return to Work</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Guidelines</Keyword><Keyword MajorTopicYN="N">Long-COVID</Keyword><Keyword MajorTopicYN="N">Management</Keyword><Keyword MajorTopicYN="N">Systematic review</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>11</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>2</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>2</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>2</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>6</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>2</Month><Day>19</Day><Hour>20</Hour><Minute>10</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>2</Month><Day>17</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35182760</ArticleId><ArticleId IdType="pmc">PMC8849856</ArticleId><ArticleId IdType="doi">10.1016/j.cmi.2022.02.018</ArticleId><ArticleId IdType="pii">S1198-743X(22)00092-1</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Peghin M., Palese A., Venturini M., De Martino M., Gerussi V., Graziano E., et al. Post-COVID-19 symptoms 6 months after acute infection among hospitalized and non-hospitalized patients. Clin Microbiol Infect. 2021;27:1507&#x2013;1513.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8180450</ArticleId><ArticleId IdType="pubmed">34111579</ArticleId></ArticleIdList></Reference><Reference><Citation>Office for National Statistics Updated estimates of the prevalence of long COVID symptoms. https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/healthandlifeexpectancies/adhocs/12788updatedestimatesoftheprevalenceoflongcovidsymptoms Available at:</Citation></Reference><Reference><Citation>Worldometers. Coronavirus cases. https://www.worldometers.info/coronavirus/ Available at:</Citation></Reference><Reference><Citation>Burke M.J., del Rio C. Long COVID has exposed medicine&#x2019;s blind-spot. Lancet Infect Dis. 2021;21:1062&#x2013;1064.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8213360</ArticleId><ArticleId IdType="pubmed">34153235</ArticleId></ArticleIdList></Reference><Reference><Citation>Sivan M., Taylor S. NICE guideline on long COVID. BMJ. 2020;371:m4938.</Citation><ArticleIdList><ArticleId IdType="pubmed">33361141</ArticleId></ArticleIdList></Reference><Reference><Citation>Sis&#xf3;-Almirall A., Brito-Zer&#xf3;n P., Conangla Ferr&#xed;n L., Kostov B., Moragas Moreno A., Mestres J., et al. Long COVID-19: proposed primary care clinical guidelines for diagnosis and disease management. Int J Environ Res Public Health. 2021;18:4350.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8073248</ArticleId><ArticleId IdType="pubmed">33923972</ArticleId></ArticleIdList></Reference><Reference><Citation>Autorit&#xe9; de Sant&#xe9; Haute. Fiches r&#xe9;ponses rapides dans le cadre du COVID-19 de la HAS&#x2013;Sympt&#xf4;mes prolong&#xe9;s suite &#xe0; une COVID-19 de l&#x2019;adulte&#x2013;Diagnostic et prise en charge. https://www.has-sante.fr/jcms/p_3237041/fr/symptomes-prolonges-suite-a-une-covid-19-de-l-adulte-diagnostic-et-prise-en-charge Available at:</Citation></Reference><Reference><Citation>WHO . WHO; Geneva, Switzerland: 2021. Living guidance for clinical management of COVID-19.</Citation></Reference><Reference><Citation>Guidelines International Network Resources. https://g-i-n.net/get-involved/resources/ Available at:</Citation></Reference><Reference><Citation>McMaster University COVID-END: COVID-19 evidence network to support decision-making. https://globalhealthoffice.mcmaster.ca/covid-end-evidence-network-to-support-decision-making/ Available at:</Citation></Reference><Reference><Citation>Coronavirus Cochrane. (COVID-19): special collections. https://www.cochrane.org/coronavirus-covid-19-resources/special-collections Available at:</Citation></Reference><Reference><Citation>Moher D., Shamseer L., Clarke M., Ghersi D., Liberati A., Petticrew M., et al. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Syst Rev. 2015;4:1.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4320440</ArticleId><ArticleId IdType="pubmed">25554246</ArticleId></ArticleIdList></Reference><Reference><Citation>Shea B.J., Reeves B.C., Wells G., Thuku M., Hamel C., Moran J., et al. AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both. BMJ. 2017;358:j4008.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5833365</ArticleId><ArticleId IdType="pubmed">28935701</ArticleId></ArticleIdList></Reference><Reference><Citation>Cumpston M., Li T., Page M.J., Chandler J., Welch V.A., Higgins J.P., et al. Updated guidance for trusted systematic reviews: a new edition of the Cochrane Handbook for Systematic Reviews of Interventions. Cochrane Database Syst Rev. 2019;10:ED000142.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10284251</ArticleId><ArticleId IdType="pubmed">31643080</ArticleId></ArticleIdList></Reference><Reference><Citation>Wells G.A., Shea B., O'Connell D., Peterson J., Welch V., Losos M., et al.  The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomized studies in meta-analyses. http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp Available at:</Citation></Reference><Reference><Citation>Kavanagh B.P. The GRADE system for rating clinical guidelines. PLoS Med. 2009;6</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2735782</ArticleId><ArticleId IdType="pubmed">19753107</ArticleId></ArticleIdList></Reference><Reference><Citation>Soriano J.B., Murthy S., Marshall J.C., Relan P., Diaz J.V. WHO clinical case definition working group on post-COVID-19 condition. A clinical case definition of post-COVID-19 condition by a Delphi consensus. Lancet Infect Dis. 2021;S1473&#x2013;3099 00703&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8691845</ArticleId><ArticleId IdType="pubmed">34951953</ArticleId></ArticleIdList></Reference><Reference><Citation>Centers for Disease Control and Prevention  COVID-19 and your health. https://www.cdc.gov/coronavirus/2019-ncov/long-term-effects/index.html Available at:</Citation><ArticleIdList><ArticleId IdType="pubmed">35324136</ArticleId></ArticleIdList></Reference><Reference><Citation>National Institutes of Health  NIH launches new initiative to study &#x201c;Long COVID&#x201d;. https://www.nih.gov/about-nih/who-we-are/nih-director/statements/nih-launches-new-initiative-study-long-covid Available at:</Citation></Reference><Reference><Citation>Lopez-Leon S., Wegman-Ostrosky T., Perelman C., Sepulveda R., Rebolledo P.A., Cuapio A., et al. More than 50 long-term effects of COVID-19: a systematic review and meta-analysis. Sci Rep. 2021;11:16144.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8352980</ArticleId><ArticleId IdType="pubmed">34373540</ArticleId></ArticleIdList></Reference><Reference><Citation>Cares-Marambio K., Montenegro-Jim&#xe9;nez Y., Torres-Castro R., Vera-Uribe R., Torralba Y., Alsina-Restoy X., et al. Prevalence of potential respiratory symptoms in survivors of hospital admission after coronavirus disease 2019 (COVID-19): a systematic review and meta-analysis. Chron Respir Dis. 2021;18 14799731211002240.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7975482</ArticleId><ArticleId IdType="pubmed">33729021</ArticleId></ArticleIdList></Reference><Reference><Citation>Song W.J., Hui C.K.M., Hull J.H., Birring S.S., McGarvey L., Mazzone S.B., et al. Confronting COVID-19-associated cough and the post-COVID syndrome: role of viral neurotropism, neuroinflammation, and neuroimmune responses. Lancet Respir Med. 2021;9:533&#x2013;544.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8041436</ArticleId><ArticleId IdType="pubmed">33857435</ArticleId></ArticleIdList></Reference><Reference><Citation>Iqbal F.M., Lam K., Sounderajah V., Clarke J.M., Ashrafian H., Darzi A. Characteristics and predictors of acute and chronic post-COVID syndrome: a systematic review and meta-analysis. EClinicalMedicine. 2021;36:100899.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8141371</ArticleId><ArticleId IdType="pubmed">34036253</ArticleId></ArticleIdList></Reference><Reference><Citation>Long Q., Li J., Hu X., Bai Y., Zheng Y., Gao Z. Follow-ups on persistent symptoms and pulmonary function among post-acute COVID-19 patients: a systematic review and meta-analysis. Front Med (Lausanne) 2021;8:702635.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8448290</ArticleId><ArticleId IdType="pubmed">34540862</ArticleId></ArticleIdList></Reference><Reference><Citation>Michelen M., Manoharan L., Elkheir N., Cheng V., Dagens A., Hastie C., et al. Characterising long COVID: a living systematic review. BMJ Glob Health. 2021;6</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8478580</ArticleId><ArticleId IdType="pubmed">34580069</ArticleId></ArticleIdList></Reference><Reference><Citation>Sanchez-Ramirez D.C., Normand K., Zhaoyun Y., Torres-Castro R. Long-term impact of COVID-19: a systematic review of the literature and meta-analysis. Biomedicines. 2021;9:900.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8389585</ArticleId><ArticleId IdType="pubmed">34440104</ArticleId></ArticleIdList></Reference><Reference><Citation>Jennings G., Monaghan A., Xue F., Mockler D., Romero-Ortu&#xf1;o R. A&#xa0;systematic review of persistent symptoms and residual abnormal functioning following acute COVID-19: ongoing symptomatic phase vs. post-COVID-19 syndrome. J&#xa0;Clin Med. 2021;10:5913.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8708187</ArticleId><ArticleId IdType="pubmed">34945213</ArticleId></ArticleIdList></Reference><Reference><Citation>Boscolo-Rizzo P., Guida F., Polesel J., Marcuzzo A.V., Capriotti V., D&#x2019;Alessandro A., et al. Sequelae in adults at 12 months after mild-to-moderate coronavirus disease 2019 (COVID-19) Int Forum Allergy Rhinol. 2021;11:1685&#x2013;1688.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9291310</ArticleId><ArticleId IdType="pubmed">34109765</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang L., Yao Q., Gu X., Wang Q., Ren L., Wang Y., et al. 1-year outcomes in hospital survivors with COVID-19: a longitudinal cohort study. Lancet. 2021;398:747&#x2013;758.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8389999</ArticleId><ArticleId IdType="pubmed">34454673</ArticleId></ArticleIdList></Reference><Reference><Citation>Yong S.J. Long COVID or post-COVID-19 syndrome: putative pathophysiology, risk factors, and treatments. Infect Dis (Lond) 2021:1&#x2013;18.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8146298</ArticleId><ArticleId IdType="pubmed">34024217</ArticleId></ArticleIdList></Reference><Reference><Citation>Nalbandian A., Sehgal K., Gupta A., Madhavan M.V., McGroder C., Stevens J.S., et al. Post-acute COVID-19 syndrome. Nat Med. 2021;27:601&#x2013;615.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8893149</ArticleId><ArticleId IdType="pubmed">33753937</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie Y., Bowe B., Al-Aly Z. Burdens of post-acute sequelae of COVID-19 by severity of acute infection, demographics and health status. Nat Commun. 2021;12:6571.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8589966</ArticleId><ArticleId IdType="pubmed">34772922</ArticleId></ArticleIdList></Reference><Reference><Citation>Sigfrid L., Drake T.M., Pauley E., Jesudason E.C., Olliaro P., Lim W.S., et al. Long COVID in adults discharged from UK hospitals after Covid-19: a prospective, multicentre cohort study using the ISARIC WHO Clinical Characterisation Protocol. Lancet Reg Health Eur. 2021;8:100186.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8343377</ArticleId><ArticleId IdType="pubmed">34386785</ArticleId></ArticleIdList></Reference><Reference><Citation>Bai F., Tomasoni D., Falcinella C., Barbanotti D., Castoldi R., Mul&#xe8; G., et al. Female gender is associated with long COVID syndrome: a prospective cohort study. Clin Microbiol Infect. 2021;S1198&#x2013;743X 00629&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8575536</ArticleId><ArticleId IdType="pubmed">34763058</ArticleId></ArticleIdList></Reference><Reference><Citation>Akter F., Mannan A., Mehedi H.M.H., Rob M.A., Ahmed S., Salauddin A., et al. Clinical characteristics and short term outcomes after recovery from COVID-19 in patients with and without diabetes in Bangladesh. Diabetes Metab Syndr. 2020;14:2031&#x2013;2038.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7575434</ArticleId><ArticleId IdType="pubmed">33113469</ArticleId></ArticleIdList></Reference><Reference><Citation>Estiri H., Strasser Z.H., Brat G.A., Semenov Y.R. Consortium for Characterization of COVID-19 by EHR (4CE), Patel CJ et&#xa0;al. Evolving phenotypes of non-hospitalized patients that indicate long COVID. BMC Med. 2021;19:249.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8474909</ArticleId><ArticleId IdType="pubmed">34565368</ArticleId></ArticleIdList></Reference><Reference><Citation>Mohiuddin Chowdhury A.T.M., Karim M.R., Ali M.A., Islam J., Li Y., He S. Clinical characteristics and the long-term post-recovery manifestations of the COVID-19 patients&#x2013;A prospective multicenter cross-sectional study. Front Med (Lausanne) 2021;8:663670.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8416537</ArticleId><ArticleId IdType="pubmed">34490284</ArticleId></ArticleIdList></Reference><Reference><Citation>Townsend L., Fogarty H., Dyer A., Martin-Loeches I., Bannan C., Nadarajan P., et al. Prolonged elevation of D-dimer levels in convalescent COVID-19 patients is independent of the acute phase response. J&#xa0;Thromb Haemost. 2021;19:1064&#x2013;1070.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8013297</ArticleId><ArticleId IdType="pubmed">33587810</ArticleId></ArticleIdList></Reference><Reference><Citation>Puntmann V.O., Carerj M.L., Wieters I., Fahim M., Arendt C., Hoffmann J., et al. Outcomes of cardiovascular magnetic resonance imaging in patients recently recovered from coronavirus disease 2019 (COVID-19) JAMA Cardiol. 2020;5:1265&#x2013;1273.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7385689</ArticleId><ArticleId IdType="pubmed">32730619</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramadan M.S., Bertolino L., Zampino R. Durante-mangoni E, monaldi hospital cardiovascular infection study group. Cardiac sequelae after coronavirus disease 2019 recovery: a systematic review. Clin Microbiol Infect. 2021;27:1250&#x2013;1261.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8220864</ArticleId><ArticleId IdType="pubmed">34171458</ArticleId></ArticleIdList></Reference><Reference><Citation>Trimboli P., Cappelli C., Croce L., Scappaticcio L., Chiovato L., Rotondi M. COVID-19-associated subacute thyroiditis: evidence-based data from a systematic review. Front Endocrinol (Lausanne) 2021;12:707726.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8511511</ArticleId><ArticleId IdType="pubmed">34659109</ArticleId></ArticleIdList></Reference><Reference><Citation>Truffaut L., Demey L., Bruyneel A.V., Roman A., Alard S., De Vos N., et al. Post-discharge critical COVID-19 lung function related to severity of radiologic lung involvement at admission. Respir Res. 2021;22:29.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7819622</ArticleId><ArticleId IdType="pubmed">33478527</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu Q., Zhong L., Li H., Guo J., Li Y., Hou X., et al. A&#xa0;follow-up study of lung function and chest computed tomography at 6 months after discharge in patients with coronavirus disease 2019. Can Respir J. 2021;2021:6692409.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7881736</ArticleId><ArticleId IdType="pubmed">33628349</ArticleId></ArticleIdList></Reference><Reference><Citation>Qin W., Chen S., Zhang Y., Dong F., Zhang Z., Hu B., et al. Diffusion capacity abnormalities for carbon monoxide in patients with COVID-19 at 3-month follow-up. Eur Respir J. 2021;58:2003677.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7877322</ArticleId><ArticleId IdType="pubmed">33574077</ArticleId></ArticleIdList></Reference><Reference><Citation>So M., Kabata H., Fukunaga K., Takagi H., Kuno T. Radiological and functional lung sequelae of COVID-19: a systematic review and meta-analysis. BMC Pulm Med. 2021;21:97.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7983097</ArticleId><ArticleId IdType="pubmed">33752639</ArticleId></ArticleIdList></Reference><Reference><Citation>George P.M., Wells A.U., Jenkins R.G. Pulmonary fibrosis and COVID-19: the potential role for antifibrotic therapy. Lancet Respir Med. 2020;8:807&#x2013;815.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7228727</ArticleId><ArticleId IdType="pubmed">32422178</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C., Huang L., Wang Y., Li X., Ren L., Gu X., et al. 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. Lancet. 2021;397:220&#x2013;232.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7833295</ArticleId><ArticleId IdType="pubmed">33428867</ArticleId></ArticleIdList></Reference><Reference><Citation>Smet J., Stylemans D., Hanon S., Ilsen B., Verbanck S., Vanderhelst E. Clinical status and lung function 10 weeks after severe SARS-CoV-2 infection. Respir Med. 2021;176:106276.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7701883</ArticleId><ArticleId IdType="pubmed">33278758</ArticleId></ArticleIdList></Reference><Reference><Citation>Stylemans D., Smet J., Hanon S., Schuermans D., Ilsen B., Vandemeulebroucke J., et al. Evolution of lung function and chest CT 6 months after COVID-19 pneumonia: real-life data from a Belgian University Hospital. Respir Med. 2021;182:106421.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8053365</ArticleId><ArticleId IdType="pubmed">33901788</ArticleId></ArticleIdList></Reference><Reference><Citation>Guler S.A., Ebner L., Aubry-Beigelman C., Bridevaux P.-O., Brutsche M., Clarenbach C., et al. Pulmonary function and radiological features 4 months after COVID-19: first results from the national prospective observational Swiss COVID-19 lung study. Eur Respir J. 2021;57:2003690.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8082329</ArticleId><ArticleId IdType="pubmed">33419891</ArticleId></ArticleIdList></Reference><Reference><Citation>van den Borst B., Peters J.B., Brink M., Schoon Y., Bleeker-Rovers C.P., Schers H., et al. Comprehensive health assessment three months after recovery from acute COVID-19. Clin Infect Dis. 2020 ciaa1750.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7717214</ArticleId><ArticleId IdType="pubmed">33220049</ArticleId></ArticleIdList></Reference><Reference><Citation>Mallia P., Meghji J., Wong B., Kumar K., Pilkington V., Chhabra S., et al. Symptomatic, biochemical and radiographic recovery in patients with COVID-19. BMJ Open Respir Res. 2021:8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8029037</ArticleId><ArticleId IdType="pubmed">33827856</ArticleId></ArticleIdList></Reference><Reference><Citation>D&#x2019;Cruz R.F., Waller M.D., Perrin F., Periselneris J., Norton S., Smith L.J., et al. Chest radiography is a poor predictor of respiratory symptoms and functional impairment in survivors of severe COVID-19 pneumonia. ERJ Open Res. 2021;7</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7585700</ArticleId><ArticleId IdType="pubmed">33575312</ArticleId></ArticleIdList></Reference><Reference><Citation>Alarc&#xf3;n-Rodr&#xed;guez J., Fern&#xe1;ndez-Velilla M., Ure&#xf1;a-Vacas A., Mart&#xed;n-Pinacho J.J., Rigual-Bobillo J.A., Jauregu&#xed;zar-Oriol A., et al. Radiological management and follow-up of post-COVID-19 patients. Radiologia (Engl Ed) 2021;63:258&#x2013;269.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8015401</ArticleId><ArticleId IdType="pubmed">33726915</ArticleId></ArticleIdList></Reference><Reference><Citation>Arnold D.T., Hamilton F.W., Milne A., Morley A.J., Viner J., Attwood M., et al. Patient outcomes after hospitalisation with COVID-19 and implications for follow-up: results from a prospective UK cohort. Thorax. 2021;76:399&#x2013;401.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7716340</ArticleId><ArticleId IdType="pubmed">33273026</ArticleId></ArticleIdList></Reference><Reference><Citation>Das K.M., Lee E.Y., Singh R., Enani M.A., Al Dossari K., Van Gorkom K., et al. Follow-up chest radiographic findings in patients with MERS-CoV after recovery. Indian J Radiol Imaging. 2017;27:342&#x2013;349.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5644332</ArticleId><ArticleId IdType="pubmed">29089687</ArticleId></ArticleIdList></Reference><Reference><Citation>Hui D.S., Joynt G.M., Wong K.T., Gomersall C.D., Li T.S., Antonio G., et al. Impact of severe acute respiratory syndrome (SARS) on pulmonary function, functional capacity and quality of life in a cohort of survivors. Thorax. 2005;60:401&#x2013;409.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1758905</ArticleId><ArticleId IdType="pubmed">15860716</ArticleId></ArticleIdList></Reference><Reference><Citation>Froidure A., Mahsouli A., Liistro G., De Greef J., Belkhir L., G&#xe9;rard L., et al. Integrative respiratory follow-up of severe COVID-19 reveals common functional and lung imaging sequelae. Respir Med. 2021;181:106383.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8019490</ArticleId><ArticleId IdType="pubmed">33839588</ArticleId></ArticleIdList></Reference><Reference><Citation>Balbi M., Conti C., Imeri G., Caroli A., Surace A., Corsi A., et al. Post-discharge chest CT findings and pulmonary function tests in severe COVID-19 patients. Eur J Radiol. 2021;138:109676.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7980523</ArticleId><ArticleId IdType="pubmed">33798931</ArticleId></ArticleIdList></Reference><Reference><Citation>Gonz&#xe1;lez J., Ben&#xed;tez I.D., Carmona P., Santisteve S., Monge A., Moncus&#xed;-Moix A., et al. Pulmonary function and radiologic features in survivors of critical COVID-19: a 3-month prospective cohort. Chest. 2021;160:187&#x2013;198.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7930807</ArticleId><ArticleId IdType="pubmed">33676998</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang Y., Tan C., Wu J., Chen M., Wang Z., Luo L., et al. Impact of coronavirus disease 2019 on pulmonary function in early convalescence phase. Respir Res. 2020;21:163.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7323373</ArticleId><ArticleId IdType="pubmed">32600344</ArticleId></ArticleIdList></Reference><Reference><Citation>Han X., Fan Y., Alwalid O., Li N., Jia X., Yuan M., et al. Six-month follow-up chest CT findings after severe COVID-19 pneumonia. Radiology. 2021;299:E177&#x2013;E186.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7841877</ArticleId><ArticleId IdType="pubmed">33497317</ArticleId></ArticleIdList></Reference><Reference><Citation>Raman B., Cassar M.P., Tunnicliffe E.M., Filippini N., Griffanti L., Alfaro-Almagro F., et al. Medium-term effects of SARS-CoV-2 infection on multiple vital organs, exercise capacity, cognition, quality of life and mental health, post-hospital discharge. EClinicalMedicine. 2021;31:100683.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7808914</ArticleId><ArticleId IdType="pubmed">33490928</ArticleId></ArticleIdList></Reference><Reference><Citation>Lewek J., Jatczak-Pawlik I., Maciejewski M., Jankowski P., Banach M. COVID-19 and cardiovascular complications&#x2013;Preliminary results of the LATE-COVID study. Arch Med Sci. 2021;17:818&#x2013;822.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8130484</ArticleId><ArticleId IdType="pubmed">34025853</ArticleId></ArticleIdList></Reference><Reference><Citation>Tudoran C., Tudoran M., Pop G.N., Giurgi-Oncu C., Cut T.G., Lazureanu V.E., et al. Associations between the severity of the post-acute COVID-19 syndrome and echocardiographic abnormalities in previously healthy outpatients following infection with SARS-CoV-2. Biology (Basel) 2021;10</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8226755</ArticleId><ArticleId IdType="pubmed">34073342</ArticleId></ArticleIdList></Reference><Reference><Citation>Hayama H., Ide S., Moroi M., Kitami Y., Bekki N., Kubota S., et al. Elevated high-sensitivity troponin is associated with subclinical cardiac dysfunction in patients recovered from coronavirus disease 2019. Glob Health Med. 2021;3:95&#x2013;101.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8071685</ArticleId><ArticleId IdType="pubmed">33937572</ArticleId></ArticleIdList></Reference><Reference><Citation>Sonnweber T., Sahanic S., Pizzini A., Luger A., Schwabl C., Sonnweber B., et al. Cardiopulmonary recovery after COVID-19: an observational prospective multicentre trial. Eur Respir J. 2021;57</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7736754</ArticleId><ArticleId IdType="pubmed">33303539</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma&#x142;ek &#x141;.A., Marczak M., Mi&#x142;osz-Wieczorek B., Konopka M., Braksator W., Drygas W., et al. Cardiac involvement in consecutive elite athletes recovered from Covid-19: a magnetic resonance study. J&#xa0;Magn Reson Imaging. 2021;53:1723&#x2013;1729.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8014772</ArticleId><ArticleId IdType="pubmed">33474768</ArticleId></ArticleIdList></Reference><Reference><Citation>Pan C., Zhang Z., Luo L., Wu W., Jia T., Lu L., et al. Cardiac T1 and T2 mapping showed myocardial involvement in recovered COVID-19 patients initially considered devoid of cardiac damage. J&#xa0;Magn Reson Imaging. 2021;54:421&#x2013;428.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8014142</ArticleId><ArticleId IdType="pubmed">33590944</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang H., Li R., Zhou Z., Jiang H., Yan Z., Tao X., et al. Cardiac involvement in COVID-19 patients: mid-term follow up by cardiovascular magnetic resonance. J&#xa0;Cardiovasc Magn Reson. 2021;23:14.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7904320</ArticleId><ArticleId IdType="pubmed">33627143</ArticleId></ArticleIdList></Reference><Reference><Citation>Dennis A., Wamil M., Alberts J., Oben J., Cuthbertson D.J., Wootton D., et al. Multiorgan impairment in low-risk individuals with post-COVID-19 syndrome: a prospective, community-based study. BMJ Open. 2021;11</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8727683</ArticleId><ArticleId IdType="pubmed">33785495</ArticleId></ArticleIdList></Reference><Reference><Citation>Joy G., Artico J., Kurdi H., Seraphim A., Lau C., Thornton G.D., et al. Prospective case-control study of cardiovascular abnormalities 6 months following mild COVID-19 in healthcare workers. JACC Cardiovasc Imaging. 2021;14:2155&#x2013;2166.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8105493</ArticleId><ArticleId IdType="pubmed">33975819</ArticleId></ArticleIdList></Reference><Reference><Citation>Hassani N.S., Talakoob H., Karim H., Bazargany M.H.M., Rastad H. Cardiac magnetic resonance imaging findings in 2954 COVID-19 adult survivors: a comprehensive systematic review. J&#xa0;Magn Reson Imaging. 2022;55:866&#x2013;880.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8427049</ArticleId><ArticleId IdType="pubmed">34309139</ArticleId></ArticleIdList></Reference><Reference><Citation>Bellan M., Soddu D., Balbo P.E., Baricich A., Zeppegno P., Avanzi G.C., et al. Respiratory and psychophysical sequelae among patients with COVID-19 four months after hospital discharge. JAMA Netw Open. 2021;4</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7841464</ArticleId><ArticleId IdType="pubmed">33502487</ArticleId></ArticleIdList></Reference><Reference><Citation>Anastasio F., Barbuto S., Scarnecchia E., Cosma P., Fugagnoli A., Rossi G., et al. Medium-term impact of COVID-19 on pulmonary function, functional capacity and quality of life. Eur Respir J. 2021;58:2004015.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7877327</ArticleId><ArticleId IdType="pubmed">33574080</ArticleId></ArticleIdList></Reference><Reference><Citation>Lerum T.V., Aal&#xf8;kken T.M., Br&#xf8;nstad E., Aarli B., Ikdahl E., Lund K.M.A., et al. Dyspnoea, lung function and CT findings 3 months after hospital admission for COVID-19. Eur Respir J. 2021;57:2003448.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7736755</ArticleId><ArticleId IdType="pubmed">33303540</ArticleId></ArticleIdList></Reference><Reference><Citation>Shah A.S., Wong A.W., Hague C.J., Murphy D.T., Johnston J.C., Ryerson C.J., et al. A&#xa0;prospective study of 12-week respiratory outcomes in COVID-19-related hospitalisations. Thorax. 2021;76:402&#x2013;404.</Citation><ArticleIdList><ArticleId IdType="pubmed">33273023</ArticleId></ArticleIdList></Reference><Reference><Citation>Dun Y., Liu C., Ripley-Gonzalez J.W., Liu P., Zhou N., Gong X., et al. Six-month outcomes and effect of pulmonary rehabilitation among patients hospitalized with COVID-19: a retrospective cohort study. Ann Med. 2021;53:2099&#x2013;2109.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8592619</ArticleId><ArticleId IdType="pubmed">34766857</ArticleId></ArticleIdList></Reference><Reference><Citation>Guedj E., Campion J.Y., Dudouet P., Kaphan E., Bregeon F., Tissot-Dupont H., et al. 18F-FDG brain PET hypometabolism in patients with long COVID. Eur J Nucl Med Mol Imaging. 2021;48 2823&#x2013;3.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7837643</ArticleId><ArticleId IdType="pubmed">33501506</ArticleId></ArticleIdList></Reference><Reference><Citation>Rudroff T., Workman C.D., Ponto L.L.B. 18F-FDG-PET imaging for post-COVID-19 brain and skeletal muscle alterations. Viruses. 2021;13:2283.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8625263</ArticleId><ArticleId IdType="pubmed">34835088</ArticleId></ArticleIdList></Reference><Reference><Citation>Bonazza F., Borghi L., di San Marco E.C., Piscopo K., Bai F., d&#x2019;Arminio M.A., et al. Psychological outcomes after hospitalization for COVID-19: data from a multidisciplinary follow-up screening program for recovered patients. Res Psychother. 2020;23:491.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7875065</ArticleId><ArticleId IdType="pubmed">33585298</ArticleId></ArticleIdList></Reference><Reference><Citation>Dong F., Liu H., Dai N., Yang M., Liu J. A&#xa0;living systematic review of the psychological problems in people suffering from COVID-19. J&#xa0;Affect Disord. 2021;292:172&#x2013;188.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8169237</ArticleId><ArticleId IdType="pubmed">34126309</ArticleId></ArticleIdList></Reference><Reference><Citation>Taquet M., Geddes J.R., Husain M., Luciano S., Harrison P.J. 6-month neurological and psychiatric outcomes in 236 379 survivors of COVID-19: a retrospective cohort study using electronic health records. Lancet Psychiatry. 2021;8:416&#x2013;427.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8023694</ArticleId><ArticleId IdType="pubmed">33836148</ArticleId></ArticleIdList></Reference><Reference><Citation>British Thoracic Society  BTS guidance on venous thromboembolic disease in patients with COVID-19. https://www.brit-thoracic.org.uk/document-library/quality-improvement/covid-19/bts-guidance-on-venous-thromboembolic-disease-in-patients-with-covid-19/ Available at:</Citation></Reference><Reference><Citation>National Institutes of Health  Antithrombotic therapy in patients with COVID-19. https://files.covid19treatmentguidelines.nih.gov/guidelines/section/section_10.pdf Available at:</Citation></Reference><Reference><Citation>Bikdeli B., Madhavan M.V., Jimenez D., Chuich T., Dreyfus I., Driggin E., et al. COVID-19 and thrombotic or thromboembolic disease: implications for prevention, antithrombotic therapy, and follow-up: JACC state-of-the-art review. J&#xa0;Am Coll Cardiol. 2020;75:2950&#x2013;2973.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7164881</ArticleId><ArticleId IdType="pubmed">32311448</ArticleId></ArticleIdList></Reference><Reference><Citation>American Society of Hematology COVID-19 and VTE/anticoagulation: frequently asked questions. https://www.hematology.org/covid-19/covid-19-and-vte-anticoagulation Available at:</Citation></Reference><Reference><Citation>Ramacciotti E., Barile Agati L., Calderaro D., Aguiar V.C.R., Spyropoulos A.C., de Oliveira C.C.C., et al. Rivaroxaban versus no anticoagulation for post-discharge thromboprophylaxis after hospitalisation for COVID-19 (MICHELLE): an open-label, multicentre, randomised, controlled trial. Lancet. 2022;399:50&#x2013;59.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8673881</ArticleId><ArticleId IdType="pubmed">34921756</ArticleId></ArticleIdList></Reference><Reference><Citation>Reina-Guti&#xe9;rrez S., Torres-Costoso A., Mart&#xed;nez-Vizca&#xed;no V., de Arenas-Arroyo S.N., Fern&#xe1;ndez-Rodr&#xed;guez R., Pozuelo-Carrascosa D.P. Effectiveness of pulmonary rehabilitation in interstitial lung disease including coronavirus diseases: a systematic review and meta-analysis. Arch Phys Med Rehabil. 2021;102 1989&#x2013;97.e3.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8474048</ArticleId><ArticleId IdType="pubmed">33932361</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu K., Zhang W., Yang Y., Zhang J., Li Y., Chen Y. Respiratory rehabilitation in elderly patients with COVID-19: a randomized controlled study. Complement Ther Clin Pract. 2020;39:101166.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7118596</ArticleId><ArticleId IdType="pubmed">32379637</ArticleId></ArticleIdList></Reference><Reference><Citation>Ceravolo M.G., Arienti C., de Sire A., Andrenelli E., Negrini F., Lazzarini S.G., et al. Rehabilitation and COVID-19: the Cochrane Rehabilitation 2020 rapid living systematic review. Eur J Phys Rehabil Med. 2020;56:642&#x2013;651.</Citation><ArticleIdList><ArticleId IdType="pubmed">32705860</ArticleId></ArticleIdList></Reference><Reference><Citation>de Sire A., Andrenelli E., Negrini F., Patrini M., Lazzarini S.G., Ceravolo M.G., et al. Rehabilitation and COVID-19: a rapid living systematic review by Cochrane Rehabilitation Field updated as of December 31st, 2020 and synthesis of the scientific literature of 2020. Eur J Phys Rehabil Med. 2021;57:181&#x2013;188.</Citation><ArticleIdList><ArticleId IdType="pubmed">33599442</ArticleId></ArticleIdList></Reference><Reference><Citation>Al Chikhanie Y., Veale D., Schoeffler M., P&#xe9;pin J.L., Verges S., H&#xe9;rengt F. Effectiveness of pulmonary rehabilitation in COVID-19 respiratory failure patients post-ICU. Respir Physiol Neurobiol. 2021;287:103639.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7879818</ArticleId><ArticleId IdType="pubmed">33588090</ArticleId></ArticleIdList></Reference><Reference><Citation>Hameed F., Palatulan E., Jaywant A., Said R., Lau C., Sood V., et al. Outcomes of a COVID-19 recovery program for patients hospitalized with SARS-CoV-2 infection in New York City: a prospective cohort study. PM R. 2021;13:609&#x2013;617.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8014069</ArticleId><ArticleId IdType="pubmed">33599057</ArticleId></ArticleIdList></Reference><Reference><Citation>British Society of Rehabilitation Medicine Rehabilitation in the wake of COVID-19&#x2013;A phoenix from the ashes. https://www.bsrm.org.uk/downloads/covid-19bsrmissue1-published-27-4-2020.pdf Available at:</Citation></Reference><Reference><Citation>National Institute for Health and Care Excellence  Overview: rehabilitation after critical illness in adults. https://www.nice.org.uk/guidance/cg83 Available at:</Citation><ArticleIdList><ArticleId IdType="pubmed">31804781</ArticleId></ArticleIdList></Reference><Reference><Citation>Barker-Davies R.M., O&#x2019;Sullivan O., Senaratne K.P.P., Baker P., Cranley M., Dharm-Datta S., et al. The Stanford Hall consensus statement for post-COVID-19 rehabilitation. Br J Sports Med. 2020;54:949&#x2013;959.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7418628</ArticleId><ArticleId IdType="pubmed">32475821</ArticleId></ArticleIdList></Reference><Reference><Citation>Myall K.J., Mukherjee B., Castanheira A.M., Lam J.L., Benedetti G., Mak S.M., et al. Persistent post-COVID-19 interstitial lung disease. An observational study of corticosteroid treatment. Ann Am Thorac Soc. 2021;18:799&#x2013;806.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8086530</ArticleId><ArticleId IdType="pubmed">33433263</ArticleId></ArticleIdList></Reference><Reference><Citation>Goel N., Goyal N., Nagaraja R., Kumar R. Systemic corticosteroids for management of &#x201c;long-COVID&#x201d;: an evaluation after 3 months of treatment. Monaldi Arch Chest Dis. 2021 [Epub ahead of print]</Citation><ArticleIdList><ArticleId IdType="pubmed">34730322</ArticleId></ArticleIdList></Reference><Reference><Citation>Denneny E.K., Garthwaite H.S., Heightman M.J., Porter J.C. A&#xa0;role for steroids in COVID-19-associated pneumonitis at six-week follow-up? Ann Am Thorac Soc. 2021;18:1082&#x2013;1083.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8456732</ArticleId><ArticleId IdType="pubmed">33735603</ArticleId></ArticleIdList></Reference><Reference><Citation>LaFond E., Weidman K., Lief L. Care of the postcoronavirus disease 2019 patient. Curr Opin Pulm Med. 2021;27:199&#x2013;204.</Citation><ArticleIdList><ArticleId IdType="pubmed">33606410</ArticleId></ArticleIdList></Reference><Reference><Citation>Udwadia Z.F., Koul P.A., Richeldi L. Post-COVID lung fibrosis: the tsunami that will follow the earthquake. Lung India. 2021;38:S41&#x2013;S47.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8104338</ArticleId><ArticleId IdType="pubmed">33686978</ArticleId></ArticleIdList></Reference><Reference><Citation>Momen A.B.I., Khan F., Saber S., Sultana A., Alam R.F., Raihan S.G., et al. Usefulness of pirfenidone in COVID lung: a case series. Eur J Med Health Sci. 2021;3:24&#x2013;26.</Citation></Reference><Reference><Citation>Dhooria S. A&#xa0;study of the efficacy and safety of pirfenidone vs. nintedanib in the treatment of fibrotic lung disease after coronavirus disease-19 pneumonia. https://clinicaltrials.gov/ct2/show/NCT04856111 Available at:</Citation></Reference><Reference><Citation>Molina M. Phase-II randomized clinical trial to evaluate the effect of pirfenidone compared to placebo in post-COVID-19 pulmonary fibrosis. https://clinicaltrials.gov/ct2/show/NCT04607928 Available at:</Citation></Reference><Reference><Citation>Bazdyrev E., Rusina P., Panova M., Novikov F., Grishagin I., Nebolsin V. Lung fibrosis after COVID-19: treatment prospects. Pharmaceuticals (Basel) 2021;14:807.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8398080</ArticleId><ArticleId IdType="pubmed">34451904</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Byrne L., Webster K.E., MacKeith S., Philpott C., Hopkins C., Burton M.J. Interventions for the treatment of persistent post-COVID-19 olfactory dysfunction. Cochrane Database Syst Rev. 2021;7:CD013876.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8406942</ArticleId><ArticleId IdType="pubmed">34291813</ArticleId></ArticleIdList></Reference><Reference><Citation>Addison A.B., Wong B., Ahmed T., Macchi A., Konstantinidis I., Huart C., et al. Clinical Olfactory Working Group consensus statement on the treatment of postinfectious olfactory dysfunction. J&#xa0;Allergy Clin Immunol. 2021;147:1704&#x2013;1719.</Citation><ArticleIdList><ArticleId IdType="pubmed">33453291</ArticleId></ArticleIdList></Reference><Reference><Citation>Abdelalim A.A., Mohamady A.A., Elsayed R.A., Elawady M.A., Ghallab A.F. Corticosteroid nasal spray for recovery of smell sensation in COVID-19 patients: a randomized controlled trial. Am J Otolaryngol. 2021;42:102884.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7836546</ArticleId><ArticleId IdType="pubmed">33429174</ArticleId></ArticleIdList></Reference><Reference><Citation>Mohamad S.A., Badawi A.M., Mansour H.F. Insulin fast-dissolving film for intranasal delivery via olfactory region, a promising approach for the treatment of anosmia in COVID-19 patients: design, in-vitro characterization and clinical evaluation. Int J Pharm. 2021;601:120600.</Citation><ArticleIdList><ArticleId IdType="pubmed">33862126</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong T.L., Weitzer D.J. Long COVID and myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS)&#x2013;A systemic review and comparison of clinical presentation and symptomatology. Medicina (Kaunas) 2021;57</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8145228</ArticleId><ArticleId IdType="pubmed">33925784</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith M.E.B., Haney E., McDonagh M., Pappas M., Daeges M., Wasson N., et al. Treatment of myalgic encephalomyelitis/chronic fatigue syndrome: a systematic review for a National Institutes of Health Pathways to Prevention Workshop. Ann Intern Med. 2015;162:841&#x2013;850.</Citation><ArticleIdList><ArticleId IdType="pubmed">26075755</ArticleId></ArticleIdList></Reference><Reference><Citation>Fowler-Davis S., Platts K., Thelwell M., Woodward A., Harrop D. A&#xa0;mixed-methods systematic review of post-viral fatigue interventions: are there lessons for long COVID? PLoS One. 2021;16</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8577752</ArticleId><ArticleId IdType="pubmed">34752489</ArticleId></ArticleIdList></Reference><Reference><Citation>National Institute of Health and Care Excellence  NICE draft guidance addresses the continuing debate about the best approach to the diagnosis and management of ME/CFS. https://www.nice.org.uk/news/article/nice-draft-guidance-addresses-the-continuing-debate-about-the-best-approach-to-the-diagnosis-and-management-of-me-cfs Available at:</Citation></Reference><Reference><Citation>Theoharides T.C., Cholevas C., Polyzoidis K., Politis A. Long-COVID syndrome-associated brain fog and chemofog: luteolin to the rescue. Biofactors. 2021;47:232&#x2013;241.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8250989</ArticleId><ArticleId IdType="pubmed">33847020</ArticleId></ArticleIdList></Reference><Reference><Citation>Sarkar I., Sen G., Bhattacharya M., Bhattacharyya S., Sen A. Insilico inquest reveals the efficacy of cannabis in the treatment of post-COVID-19 related neurodegeneration. J&#xa0;Biomol Struct Dyn. 2021:1&#x2013;10.</Citation><ArticleIdList><ArticleId IdType="pubmed">33810774</ArticleId></ArticleIdList></Reference><Reference><Citation>Magoon R., Bansal N., Singh A., Kashav R. Methylene blue: subduing the post-COVID-19 blues. Med Hypotheses. 2021;150:110574.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7985606</ArticleId><ArticleId IdType="pubmed">33799158</ArticleId></ArticleIdList></Reference><Reference><Citation>Nobile B., Durand M., Oli&#xe9; E., Guillaume S., Mol&#xe8;s J.P., Haffen E., et al. The anti-inflammatory effect of the tricyclic antidepressant clomipramine and its high penetration in the brain might be useful to prevent the psychiatric consequences of SARS-CoV-2 infection. Front Pharmacol. 2021;12:615695.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7985338</ArticleId><ArticleId IdType="pubmed">33767623</ArticleId></ArticleIdList></Reference><Reference><Citation>Amin-Chowdhury Z., Ladhani S.N. Causation or confounding: why controls are critical for characterizing long COVID. Nat Med. 2021;27:1129&#x2013;1130.</Citation><ArticleIdList><ArticleId IdType="pubmed">34140704</ArticleId></ArticleIdList></Reference><Reference><Citation>Amin-Chowdhury Z., Harris R.J., Aiano F., Zavala M., Bertran M., Borrow R., et al. Characterising long COVID more than 6 months after acute infection in adults; prospective longitudinal cohort study. England. 2021 2021.03.18.21253633.</Citation></Reference><Reference><Citation>Hoshijima H., Mihara T., Seki H., Hyuga S., Kuratani N., Shiga T. Incidence of long-term post-acute sequelae of SARS-CoV-2 infection related to pain and other symptoms: a living systematic review and meta-analysis. MedRxiv. 2021 2021.04.08.21255109.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10686440</ArticleId><ArticleId IdType="pubmed">38019841</ArticleId></ArticleIdList></Reference><Reference><Citation>Einvik G., Dammen T., Ghanima W., Heir T., Stavem K. Prevalence and risk factors for post-traumatic stress in hospitalized and non-hospitalized COVID-19 patients. Int J Environ Res Public Health. 2021;18:2079.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7924607</ArticleId><ArticleId IdType="pubmed">33672759</ArticleId></ArticleIdList></Reference><Reference><Citation>Havervall S., Rosell A., Phillipson M., Mangsbo S.M., Nilsson P., Hober S., et al. Symptoms and functional impairment assessed 8 months after mild COVID-19 among health care workers. JAMA. 2021;325:2015&#x2013;2016.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8027932</ArticleId><ArticleId IdType="pubmed">33825846</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou F., Tao M., Shang L., Liu Y., Pan G., Jin Y., et al. Assessment of sequelae of COVID-19 nearly 1 year after diagnosis. Front Med (Lausanne) 2021;8:717194.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8649686</ArticleId><ArticleId IdType="pubmed">34888318</ArticleId></ArticleIdList></Reference><Reference><Citation>Carf&#xec; A., Bernabei R., Landi F. Gemelli against COVID-19 post-acute care study group. Persistent symptoms in patients after acute COVID-19. JAMA. 2020;324:603&#x2013;605.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7349096</ArticleId><ArticleId IdType="pubmed">32644129</ArticleId></ArticleIdList></Reference><Reference><Citation>Del Brutto O.H., Wu S., Mera R.M., Costa A.F., Recalde B.Y., Issa N.P. Cognitive decline among individuals with history of mild symptomatic SARS-CoV-2 infection: a longitudinal prospective study nested to a population cohort. Eur J Neurol. 2021;28:3245&#x2013;3253.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8014083</ArticleId><ArticleId IdType="pubmed">33576150</ArticleId></ArticleIdList></Reference><Reference><Citation>Gaber T.A.Z.K., Ashish A., Unsworth A. Persistent post-covid symptoms in healthcare workers. Occup Med (Lond) 2021;71:144&#x2013;146.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8083525</ArticleId><ArticleId IdType="pubmed">33830208</ArticleId></ArticleIdList></Reference><Reference><Citation>Miskowiak K.W., Johnsen S., Sattler S.M., Nielsen S., Kunalan K., Rungby J., et al. Cognitive impairments four months after COVID-19 hospital discharge: pattern, severity and association with illness variables. Eur Neuropsychopharmacol. 2021;46:39&#x2013;48.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8006192</ArticleId><ArticleId IdType="pubmed">33823427</ArticleId></ArticleIdList></Reference><Reference><Citation>Nersesjan V., Amiri M., Lebech A.M., Roed C., Mens H., Russell L., et al. Central and peripheral nervous system complications of COVID-19: a prospective tertiary center cohort with 3-month follow-up. J&#xa0;Neurol. 2021;268:3086&#x2013;3104.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7803470</ArticleId><ArticleId IdType="pubmed">33438076</ArticleId></ArticleIdList></Reference><Reference><Citation>Petersen M.S., Kristiansen M.F., Hanusson K.D., Danielsen M.E., &#xc1; Steig B., Gaini S., et al. Long COVID in the Faroe Islands&#x2013;A longitudinal study among non-hospitalized patients. Clin Infect Dis. 2020:ciaa1792.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7799340</ArticleId><ArticleId IdType="pubmed">33252665</ArticleId></ArticleIdList></Reference><Reference><Citation>Rass V., Beer R., Schiefecker A.J., Kofler M., Lindner A., Mahlknecht P., et al. Neurological outcome and quality of life 3 months after COVID-19: a prospective observational cohort study. Eur J Neurol. 2021;28:3348&#x2013;3359.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8250725</ArticleId><ArticleId IdType="pubmed">33682276</ArticleId></ArticleIdList></Reference><Reference><Citation>Simani L., Ramezani M., Darazam I.A., Sagharichi M., Aalipour M.A., Ghorbani F., et al. Prevalence and correlates of chronic fatigue syndrome and post-traumatic stress disorder after the outbreak of the COVID-19. J&#xa0;Neurovirol. 2021;27:154&#x2013;159.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7852482</ArticleId><ArticleId IdType="pubmed">33528827</ArticleId></ArticleIdList></Reference><Reference><Citation>Stavem K., Ghanima W., Olsen M.K., Gilboe H.M., Einvik G. Prevalence and determinants of fatigue after COVID-19 in non-hospitalized subjects: a population-based study. Int J Environ Res Public Health. 2021;18:2030.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7921928</ArticleId><ArticleId IdType="pubmed">33669714</ArticleId></ArticleIdList></Reference><Reference><Citation>Su&#xe1;rez-Robles M., Iguaran-Berm&#xfa;dez M.D.R., Garc&#xed;a-Klepizg J.L., Lorenzo-Villalba N., M&#xe9;ndez-Bail&#xf3;n M. Ninety days post-hospitalization evaluation of residual COVID-19 symptoms through a phone call check list. Pan Afr Med J. 2020;37:289.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7881918</ArticleId><ArticleId IdType="pubmed">33654513</ArticleId></ArticleIdList></Reference><Reference><Citation>Sykes D.L., Holdsworth L., Jawad N., Gunasekera P., Morice A.H., Crooks M.G. Post-COVID-19 symptom burden: what is long COVID and how should we manage it? Lung. 2021;199:113&#x2013;119.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7875681</ArticleId><ArticleId IdType="pubmed">33569660</ArticleId></ArticleIdList></Reference><Reference><Citation>Taboada M., Moreno E., Cari&#xf1;ena A., Rey T., Pita-Romero R., Leal S., et al. Quality of life, functional status, and persistent symptoms after intensive care of COVID-19 patients. Br J Anaesth. 2021;126:e110&#x2013;e113.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7833644</ArticleId><ArticleId IdType="pubmed">33413976</ArticleId></ArticleIdList></Reference><Reference><Citation>Tarsitani L., Vassalini P., Koukopoulos A., Borrazzo C., Alessi F., Di Nicolantonio C., et al. Post-traumatic stress disorder among COVID-19 survivors at 3-month follow-up after hospital discharge. J&#xa0;Gen Intern Med. 2021;36:1702&#x2013;1707.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8007055</ArticleId><ArticleId IdType="pubmed">33782888</ArticleId></ArticleIdList></Reference><Reference><Citation>Venturelli S., Benatti S.V., Casati M., Binda F., Zuglian G., Imeri G., et al. Surviving COVID-19 in Bergamo province: a post-acute outpatient re-evaluation. Epidemiol Infect. 2021;149:e32.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7873454</ArticleId><ArticleId IdType="pubmed">33461632</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao Y.M., Shang Y.M., Song W.B., Li Q.Q., Xie H., Xu Q.F., et al. Follow-up study of the pulmonary function and related physiological characteristics of COVID-19 survivors three months after recovery. EClinicalMedicine. 2020;25:100463.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7361108</ArticleId><ArticleId IdType="pubmed">32838236</ArticleId></ArticleIdList></Reference><Reference><Citation>Ziauddeen N., Gurdasani D., O&#x2019;Hara M.E., Hastie C., Roderick P., Yao G., et al. Characteristics of long COVID: findings from a social media survey. MedRxiv. 2021 2021.03.21.21253968.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8903286</ArticleId><ArticleId IdType="pubmed">35259179</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo T., Jiang F., Liu Y., Zhao Y., Li Y., Wang Y. Respiratory outcomes in patients following COVID-19-related hospitalization: a meta-analysis. Front Mol Biosci. 2021;8:750558.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8528387</ArticleId><ArticleId IdType="pubmed">34692771</ArticleId></ArticleIdList></Reference><Reference><Citation>Jalu&#x161;i&#x107; Glun&#x10d;i&#x107; T., Mur&#x161;i&#x107; D., Basara L., Vrani&#x107; L., Mo&#x107;an A., Jankovi&#x107; Makek M., et al. Overview of symptoms of ongoing symptomatic and post-COVID-19 patients who were referred to pulmonary rehabilitation&#x2013;First single-centre experience in Croatia. Psychiatr Danub. 2021;33:565&#x2013;571.</Citation><ArticleIdList><ArticleId IdType="pubmed">34718282</ArticleId></ArticleIdList></Reference><Reference><Citation>Cort&#xe9;s-Telles A., L&#xf3;pez-Romero S., Figueroa-Hurtado E., Pou-Aguilar Y.N., Wong A.W., Milne K.M., et al. Pulmonary function and functional capacity in COVID-19 survivors with persistent dyspnoea. Respir Physiol Neurobiol. 2021;288:103644.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7910142</ArticleId><ArticleId IdType="pubmed">33647535</ArticleId></ArticleIdList></Reference><Reference><Citation>Baranauskas M.N., Carter S.J. Evidence for impaired chronotropic responses to and recovery from 6-minute walk test in women with post-acute COVID-19 syndrome. Exp Physiol. 2021 doi: 10.1113/EP089965.</Citation><ArticleIdList><ArticleId IdType="doi">10.1113/EP089965</ArticleId><ArticleId IdType="pmc">PMC8667649</ArticleId><ArticleId IdType="pubmed">34761446</ArticleId></ArticleIdList></Reference><Reference><Citation>Betschart M., Rezek S., Unger I., Ott N., Beyer S., B&#xf6;ni A., et al. One year follow-up of physical performance and quality of life in patients surviving COVID-19: a prospective cohort study. Swiss Med Wkly. 2021;151:w30072.</Citation><ArticleIdList><ArticleId IdType="pubmed">34751538</ArticleId></ArticleIdList></Reference><Reference><Citation>Jacobson K.B., Rao M., Bonilla H., Subramanian A., Hack I., Madrigal M., et al. Patients with uncomplicated coronavirus disease 2019 (COVID-19) have long-term persistent symptoms and functional impairment similar to patients with severe COVID-19: a cautionary tale during a global pandemic. Clin Infect Dis. 2021;73:e826&#x2013;e829.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7929039</ArticleId><ArticleId IdType="pubmed">33624010</ArticleId></ArticleIdList></Reference><Reference><Citation>Aiello M., Marchi L., Calzetta L., Speroni S., Frizzelli A., Ghirardini M., et al. Coronavirus disease 2019: COSeSco&#x2013;A risk assessment score to predict the risk of pulmonary sequelae in COVID-19 patients. Respiration. 2021:1&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9059039</ArticleId><ArticleId IdType="pubmed">34673642</ArticleId></ArticleIdList></Reference><Reference><Citation>Schandl A., Hedman A., Lyng&#xe5; P., Fathi Tachinabad S., Svefors J., Ro&#xeb;l M., et al. Long-term consequences in critically ill COVID-19 patients: a prospective cohort study. Acta Anaesthesiol Scand. 2021;65:1285&#x2013;1292.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8212104</ArticleId><ArticleId IdType="pubmed">34097753</ArticleId></ArticleIdList></Reference><Reference><Citation>Aranda J., Oriol I., Mart&#xed;n M., Feria L., V&#xe1;zquez N., Rhyman N., et al. Long-term impact of COVID-19 associated acute respiratory distress syndrome. J&#xa0;Infect. 2021;83:581&#x2013;588.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8363182</ArticleId><ArticleId IdType="pubmed">34400219</ArticleId></ArticleIdList></Reference><Reference><Citation>Liao T., Meng D., Xiong L., Wu S., Yang L., Wang S., et al. Long-term effects of COVID-19 on health care workers 1-year post-discharge in Wuhan. Infect Dis Ther. 2022;11:145&#x2013;163.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8536919</ArticleId><ArticleId IdType="pubmed">34687442</ArticleId></ArticleIdList></Reference><Reference><Citation>N&#xfa;&#xf1;ez-Cort&#xe9;s R., Rivera-Lillo G., Arias-Campoverde M., Soto-Garc&#xed;a D., Garc&#xed;a-Palomera R., Torres-Castro R. Use of sit-to-stand test to assess the physical capacity and exertional desaturation in patients post COVID-19. Chron Respir Dis. 2021;18 1479973121999205.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7923980</ArticleId><ArticleId IdType="pubmed">33645261</ArticleId></ArticleIdList></Reference><Reference><Citation>Barbagelata L., Masson W., Iglesias D., Lillo E., Migone J.F., Orazi M.L., et al. Cardiopulmonary exercise testing in patients with post-COVID-19 syndrome. Med Clin (Barc) 2021;S0025&#x2013;7753 00462&#x2013;0.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8318690</ArticleId><ArticleId IdType="pubmed">34417020</ArticleId></ArticleIdList></Reference><Reference><Citation>Szekely Y., Lichter Y., Sadon S., Lupu L., Taieb P., Banai A., et al. Cardiorespiratory abnormalities in patients recovering from coronavirus disease 2019. J&#xa0;Am Soc Echocardiogr. 2021;34:1273&#x2013;1284. e9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8425293</ArticleId><ArticleId IdType="pubmed">34508837</ArticleId></ArticleIdList></Reference><Reference><Citation>Rinaldo R.F., Mondoni M., Parazzini E.M., Baccelli A., Pitari F., Brambilla E., et al. Severity does not impact on exercise capacity in COVID-19 survivors. Respir Med. 2021;187:106577.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8364146</ArticleId><ArticleId IdType="pubmed">34416618</ArticleId></ArticleIdList></Reference><Reference><Citation>Kersten J., Baumhardt M., Hartveg P., Hoyo L., H&#xfc;ll E., Imhof A., et al. Long COVID: distinction between organ damage and deconditioning. J&#xa0;Clin Med. 2021;10:3782.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8432179</ArticleId><ArticleId IdType="pubmed">34501230</ArticleId></ArticleIdList></Reference><Reference><Citation>Mohr A., Dannerbeck L., Lange T.J., Pfeifer M., Blaas S., Salzberger B., et al. Cardiopulmonary exercise pattern in patients with persistent dyspnoea after recovery from COVID-19. Multidiscip Respir Med. 2021;16:732.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7893311</ArticleId><ArticleId IdType="pubmed">33623700</ArticleId></ArticleIdList></Reference><Reference><Citation>Jahn K., Sava M., Sommer G., Schumann D.M., Bassetti S., Siegemund M., et al. Exercise capacity impairment after COVID-19 pneumonia is mainly caused by deconditioning. Eur Respir J. 2022;59:2101136.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8573604</ArticleId><ArticleId IdType="pubmed">34737222</ArticleId></ArticleIdList></Reference><Reference><Citation>Ladlow P., O&#x2019;Sullivan O., Houston A., Barker-Davies R., May S., Mills D., et al. Dysautonomia following COVID-19 is not associated with subjective limitations or symptoms but is associated with objective functional limitations. Heart Rhythm. 2021;S1547&#x2013;5271 02430&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8656177</ArticleId><ArticleId IdType="pubmed">34896622</ArticleId></ArticleIdList></Reference><Reference><Citation>&#xc1; Aparisi, Ybarra-Falc&#xf3;n C., Garc&#xed;a-G&#xf3;mez M., Tobar J., Iglesias-Echeverr&#xed;a C., Jaurrieta-Largo S., et al. Exercise ventilatory inefficiency in post-COVID-19 syndrome: insights from a prospective evaluation. J&#xa0;Clin Med. 2021;10:2591.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8230788</ArticleId><ArticleId IdType="pubmed">34208271</ArticleId></ArticleIdList></Reference><Reference><Citation>Alba G.A., Ziehr D.R., Rouvina J.N., Hariri L.P., Knipe R.S., Medoff B.D., et al. Exercise performance in patients with post-acute sequelae of SARS-CoV-2 infection compared to patients with unexplained dyspnea. EClinicalMedicine. 2021;39:101066.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8401400</ArticleId><ArticleId IdType="pubmed">34476393</ArticleId></ArticleIdList></Reference><Reference><Citation>Mancini D.M., Brunjes D.L., Lala A., Trivieri M.G., Contreras J.P., Natelson B.H. Use of cardiopulmonary stress testing for patients with unexplained dyspnea post-coronavirus disease. JACC Heart Fail. 2021;9:927&#x2013;937.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8629098</ArticleId><ArticleId IdType="pubmed">34857177</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu Y., Li X., Geng D., Mei N., Wu P.Y., Huang C.C., et al. Cerebral micro-structural changes in COVID-19 patients&#x2013;An MRI-based 3-month follow-up study. EClinicalMedicine. 2020;25:100484.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7396952</ArticleId><ArticleId IdType="pubmed">32838240</ArticleId></ArticleIdList></Reference><Reference><Citation>Sinha R.K., Sinha S., Varadharajulu G. Effectiveness of structured exercise protocol on functional performance in subjects with COVID-19. Int J Res Pharmaceut Sci. 2020 1244&#x2013;9.</Citation></Reference><Reference><Citation>Hermann M., Pekacka-Egli A.M., Witassek F., Baumgaertner R., Schoendorf S., Spielmanns M. Feasibility and efficacy of cardiopulmonary rehabilitation after COVID-19. Am J Phys Med Rehabil. 2020;99:865&#x2013;869.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7406212</ArticleId><ArticleId IdType="pubmed">32732746</ArticleId></ArticleIdList></Reference><Reference><Citation>Udina C., Ars J., Morandi A., Vilar&#xf3; J., C&#xe1;ceres C., Inzitari M. Rehabilitation in adult post-COVID-19 patients in post-acute care with therapeutic exercise. J&#xa0;Frailty Aging. 2021;10:297&#x2013;300.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7876526</ArticleId><ArticleId IdType="pubmed">34105716</ArticleId></ArticleIdList></Reference><Reference><Citation>Piquet V., Luczak C., Seiler F., Monaury J., Martini A., Ward A.B., et al. Do patients with COVID-19 benefit from rehabilitation? Functional outcomes of the first 100 patients in a COVID-19 rehabilitation unit. Arch Phys Med Rehabil. 2021;102:1067&#x2013;1074.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7857995</ArticleId><ArticleId IdType="pubmed">33548208</ArticleId></ArticleIdList></Reference><Reference><Citation>Curci C., Negrini F., Ferrillo M., Bergonzi R., Bonacci E., Camozzi D.M., et al. Functional outcome after inpatient rehabilitation in post-intensive care unit COVID-19 patients: findings and clinical implications from a real-practice retrospective study. Eur J Phys Rehabil Med. 2021;57:443&#x2013;450.</Citation><ArticleIdList><ArticleId IdType="pubmed">33393278</ArticleId></ArticleIdList></Reference><Reference><Citation>Bowles K.H., McDonald M., Barr&#xf3;n Y., Kennedy E., O&#x2019;Connor M., Mikkelsen M. Surviving COVID-19 after hospital discharge: symptom, functional, and adverse outcomes of home health recipients. Ann Intern Med. 2021;174:316&#x2013;325.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7707212</ArticleId><ArticleId IdType="pubmed">33226861</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoy D., Brooks P., Woolf A., Blyth F., March L., Bain C., et al. Assessing risk of bias in prevalence studies: modification of an existing tool and evidence of interrater agreement. J Clin Epidemiol. 2012;65:934&#x2013;939.</Citation><ArticleIdList><ArticleId IdType="pubmed">22742910</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>